Showing results (2031-2040 of 2,148) with videos related to
Sort By:
Pageof 215
Neurobiology of Aging|April 12, 2021
EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panelClaudio Babiloni, Xianghong Arakaki, Laura Bonanni, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2018
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementiaRosalinde E R Slot, Sietske A M Sikkes, Johannes Berkhof, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017Samir Gupta, Dawn Provenzale, Scott E Regenbogen, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
Colorectal Cancer Screening, Version 1.2015Dawn Provenzale, Kory Jasperson, Dennis J Ahnen, et al.American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.International Journal of Colorectal Disease|March 10, 2010
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic studyDaniel D Buchanan, Kevin Sweet, Musa Drini, et al.The Journal of Biological Chemistry|December 24, 2010
Small molecule AKAP-protein kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytesFrank Christian, Márta Szaszák, Sabine Friedl, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 13, 2018
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018Dawn Provenzale, Samir Gupta, Dennis J Ahnen, et al.Cancer Research Communications|June 5, 2024
Association of ESR1 Germline Variants with TP53 Somatic Variants in Breast Tumors in a Genome-wide StudyNijole P Tjader, Abigail J Beer, Johnny Ramroop, et al.Pageof 215